Replies to post #115954 on Biotech Values

[DewDiligence]

…is it correct to say that TEVA could possibly get an injunction which would prevent Sandoz/MNTA launching at risk for generic copaxone?

No, we cannot say that. Teva might be able to get a preliminary injunction to block the launch of generic Copaxone; however, the likelihood of Teva’s getting a PI will be diminished if the Judge believes Teva is unlikely to prevail in the Copaxone trial.